Technology
Health
Pharmaceutical
Kala Pharmaceuticals
$5.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.32 (-5.29%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell KALA and other stocks, options, ETFs, and crypto commission-free!
About KALA
Kala Pharmaceuticals, Inc. Common Stock, also called Kala Pharmaceuticals, is a biopharmaceutical company, focused on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. Read More The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Waltham, MA.
Employees
130
Headquarters
Waltham, Massachusetts
Founded
2009
Market Cap
204.99M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
146.00K
High Today
$6.12
Low Today
$5.62
Open Price
$6.05
Volume
195.93K
52 Week High
$14.45
52 Week Low
$4.03
Collections
Technology
Health
Pharmaceutical
Biopharmaceutical
Therapy
2017 IPO
US
North America
Price Paid on Robinhood
46% Lower
Right Now
52 Week Low
$4.03
Average Price Paid
$10.63
52 Week High
$17.39
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
KALA Earnings
-$0.76
-$0.63
-$0.50
-$0.37
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, Pre-Market